JCVI Reels in $43M NIAID Contract | GenomeWeb

NEW YORK (GenomeWeb News) – The J. Craig Venter Institute has landed a $43 million contract from the National Institute of Allergy and Infectious Diseases that will fund the institute's disease and human genomic sequencing efforts, JCVI said today.

JCVI will use the funds, which will be spread over five years, to support its sequencing activities as one of the National Institutes of Health's Genomic Sequencing Centers for Infectious Diseases (GSCID).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.